S-1 · primary and resale
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Wholesale-Drugs, Proprietaries & Druggists' SundriesIndustry: Medical - DistributionCountry: HKExchange: Nasdaq
DilutionScan read 25 of Cellyan Biotechnology Co., Ltd's SEC filings and found 2 warrant series, 1 shelf registration, 2 S-1 registrations and 2 completed offerings on file for HKPD. The latest dilution event on file is a registration statement on Jun 24, 2026. Analysis updated Oct 26, 2026.
Raise routes on file: effective shelf + effective S-1 · latest dilution event 132 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 24, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Issued 2026
Proposed maximum
Shares registered
Issued 2025
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Medical - Distribution, then the closest in size. All tickers A to Z